News Novartis adds to cancer reach with $3.9 billion acquisition Novartis backs ambition to be oncology world-leader
News Gilead gains CAR-T approval, undercuts rival's headline pric... Cancer cell therapy approved for aggressive blood cancer
News Novartis joins with Berkeley to tackle "undruggable" targets Project will focus on areas such as cancer and infectious diseases
News NICE recommends Bayer drug for severe short-sightedness Eylea should be funded in mCNV, says NICE
News Novartis' CAR-T drug needs new payment model, says Express S... Cost of Novartis' revolutionary therapy is obstacle, says CMO.
News New Novartis blood cancer drug approved in EU Rydapt approved in mastocytosis, related blood cancers, and AML
News AI giant Anthropic buys Coefficient Bio for $400m Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
